Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study von Alberts, S. R., Townley, P. M., Goldberg, R. M., Cha, S. S., Moore, D. F., Krook, J. E., Pitot, H. C., Fitch, T. R., Wiesenfeld, M., Mailliard, J. A., Sargent, D. J.

Volltext

Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Groupphase II study von Alberts, S.R., Townley, P.M., Goldberg, R.M., Cha, S.S., Sargent, D.J., Moore, D.F., Krook, J.E., Pitot, H.C., Fitch, T.R., Wiesenfeld, M., Mailliard, J.A.

Volltext